Tackling CSRD, Double Materiality & Other Global Regulations for Biotech Organizations
Time: 11:05 am
day: Pre-Conference Day
Details:
Uncover how growing biotech organizations with smaller teams than large pharma are complying to evolving new ESG policy and regulations. This includes a roadmap on how to comply to CSRD regulations across KPIs (and develop a human right policy) to ensure global regulatory compliance in 2024. Walk away with a roadmap to ensure regulatory compliance (globally) and secure the future of your ESG function in 2024 and beyond.
Content this session will cover:
- An overview of the global ESG regulatory environment (CSRD, SEC, California Climate Bills) and understanding the current evolutions
- How to comply to CSRD and complete a double materiality assessment in biotech organizations: understanding timelines, using the best technology, ensuring integrity of data collection, putting this into an auditable report
- Developing a Human Rights policy in accordance to CSRD and UK regulation
- How to effectively collect environmental data for compliance to CSRD: what tools and technology to use, now but also in the future and ensuring integrity of data collection
- How do you operationally set up your teams (audit, finance etc) to support ESG and sustainability reporting for compliance
